Found: 10
Select item for more details and to access through your institution.
NKp44-Derived Peptide Used in Combination Stimulates Antineoplastic Efficacy of Targeted Therapeutic Drugs.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14054, doi. 10.3390/ijms232214054
- By:
- Publication type:
- Article
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4717, doi. 10.3390/ijms23094717
- By:
- Publication type:
- Article
The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01428
- By:
- Publication type:
- Article
Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination.
- Published in:
- Current Oncology, 2022, v. 29, n. 2, p. 989, doi. 10.3390/curroncol29020084
- By:
- Publication type:
- Article
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 467, doi. 10.1159/000525188
- By:
- Publication type:
- Article
Nanowire Based Mechanostimulating Platform for Tunable Activation of Natural Killer Cells.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 26, p. 1, doi. 10.1002/adfm.202103063
- By:
- Publication type:
- Article
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-87102-4
- By:
- Publication type:
- Article
N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, p. 1, doi. 10.3389/fcimb.2020.00048
- By:
- Publication type:
- Article
Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma).
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3630, doi. 10.3390/cancers13143630
- By:
- Publication type:
- Article
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3214, doi. 10.3390/jcm9103214
- By:
- Publication type:
- Article